A 36 week pregnant woman is involved in a car crash and suffers fractures to her left femur and tibia and left ribs 4-8. What are the cardiorespiratory changes in normal pregnancy?
How do they effect her response to these injuries?
This question had two parts. Lists would suffice. For example: (a) Cardiorespiratory changes include:
• Increased blood, plasma and Rd cell volume from 6 weeks. maximal at 28 to 32 weeks
• Increased cardiac output (33% by 10 weeks.to 40-50'/o by 28 to 32 weeks)
• Decreased blood pressure due to low SVR
• Susceptibility to aorto-caval compression develops during second trimester (maximal at 36-
38 weeks)
• Cardiac hypertrophy with increased wall thickness and chamber volume.
• Left axis deviation, horizontal heart
• Hb decreased due to relative haemodilution
• Upper respiratory tract oedema and capillary engorgement
• Increased minute volume, respiratory rate, V, lV, RR. Chronic respiratory allcalosis
• Decreased FRC, RV, TLC, AWR
(b) The clinical effects on her response to the injury include:
• Larger blood volume allows blood loss to be relatively better tolerated
• Susceptible to supine hypotension
• Susceptible to basal atelectasis and hypoxia
• Difficult intubation
• High Vand low FRC means that hypoxia and hypercarbia develop rapidly with airway
obstruction. apnoea etc
This question forms a part of the "manage this pregnant trauma patient" spectrum of fellowship questions. For a general reference, one is directed to Question 3 from the first paper of 2007 (Outline the special considerations involved in the care of a pregnant patient involved in multi-trauma.). That answer also covers section (b) of the current question ("How do they effect her response to these injuries?")
The management of the pregnant poly-trauma patient is discussed elsewhere. The answer prepared for Question 3 from the first paper of 2007 is very similar: "Outline the special considerations involved in the care of a pregnant patient involved in multi-trauma.".
In summary:
Airway changes
Bag-mask ventilation becomes more difficult:
Laryngoscopy becomes more difficult:
Less time is available for intubation:
Intubation is more risky
Respiratory changes
Circulatory changes
Electrolyte and endocrine changes
Renal changes
Gastrointestinal and nutritional changes
Specific features of the cardiorespiratory changes in pregnancy can be found on the page dedicated to this topic. In brief summary, they are as follows:
The diaphragm is pushed up | by 4cm |
Tidal volume increases | by ~ 30-50% |
Respiratory rate increases | to 15-17 |
Minute volume increases | by 20-50%. |
Chest wall compliance decreases | |
Lung compliance remains the same | |
pH increases | to 740-7.47 |
PaCO2 decreases | to 30 mmHg |
PaO2 increases | to 105 mmHg |
HCO3- decreases | to 20 mmol/L |
Maternal 2,3-DPG increases | |
p50 remains the same because of alkalosis |
Heart rate | Increased (from 75 to 85-90) |
Stroke volume | Increased (from 65ml to 80-90ml) |
Cardiac output | Increased (from 5L/min to 7L/min) |
Blood pressure | Decreased |
Systemic vascular resistance | Decreased |
Pulmonary vascular resistance | Decreased |
Pulmonary artery wedge pressure | Unchanged |
Blood volume | Increased by 50% |
CVP | Unchanged |
Renal blood flow | Increased by 30-80% |
Resting oxygen consumption | Increased by 20-30% |
Colloid oncotic pressure | Decreased |
Critical Care Medicine has dedicated an entire supplement to the influence of pregnancy in critical care: Volume 33 Supplement 10 October 2005 - pg. S247-S397
Additionally, UpToDate has an excellent summary for the paying customer.
Hunter, Stewart, and Stephen C. Robson. "Adaptation of the maternal heart in pregnancy." British heart journal 68.6 (1992): 540.
Metcalfe, James, and Kent Ueland. "Maternal cardiovascular adjustments to pregnancy." Progress in cardiovascular diseases 16.4 (1974): 363-374.
You are called to see a 39 year old female driver in the Emergency Department who has been brought in by ambulance after a motor vehicle crash (head on collision). She is eight months pregnant (first pregnancy), and is complaining of abdominal pain.
(c) Please discuss the expected physiological changes associated with pregnancy and how they would impact on her management.
Multiple factors: consider the following:
Cardiovascular: vasodilated state with lower baseline BP, higher baseline HR, and higher cardiac output. Masking of initial hypovolaemia, risking foetal circulation, best monitored by foetal heart rate. Large intra-abdominal mass (uterus) puts patient at risk of supine hypotensive syndrome: need to displace uterus or position in left lateral position.
Respiratory: diagphragms pushed up, decreased FRC (need to insert ICCs higher); respiratory alkalosis (expected CO2 30, with HCO3 20): need to keep in mind when assessing blood gases and if ventilating patient. Swollen airway, larger breasts: intubation often difficult.
Gastrointestinal: decreased gastric emptying, and weakened lower oesophageal sphincter: increased risk of aspiration.
Haematological: hypercoagulable state, risk of Rh incompatibility with foetus: potential for Rhesus isoimmunisation.
Foetus: benefits from supplemental oxygen; avoid tetracyclines, quinalones, NSAIDs (premature ductal closure), etc.
The management of the pregnant poly-trauma patient is discussed elsewhere. The answer prepared for Question 3 from the first paper of 2007 is very similar: "Outline the special considerations involved in the care of a pregnant patient involved in multi-trauma.".
In summary:
Airway changes
Bag-mask ventilation becomes more difficult:
Laryngoscopy becomes more difficult:
Less time is available for intubation:
Intubation is more risky
Respiratory changes
Circulatory changes
Electrolyte and endocrine changes
Renal changes
Gastrointestinal and nutritional changes
Oh's Intensive Care manual: Chapter 64 (pp. 684) General obstetric emergencies by Winnie TP Wan and Tony Gin
Soar, Jasmeet, et al. "European Resuscitation Council Guidelines for Resuscitation 2010 Section 8. Cardiac arrest in special circumstances: Electrolyte abnormalities, poisoning, drowning, accidental hypothermia, hyperthermia, asthma, anaphylaxis, cardiac surgery, trauma, pregnancy, electrocution." Resuscitation 81.10 (2010): 1400-1433.
Mattox, Kenneth L., and Laura Goetzl. "Trauma in pregnancy." Critical care medicine 33.10 (2005): S385-S389.
DROST, THOMAS F., et al. "Major trauma in pregnant women: maternal/fetal outcome." Journal of Trauma-Injury, Infection, and Critical Care 30.5 (1990): 574-578.
A 35 year old woman with pre-eclampsia at 38 weeks gestation is transferred to ICU post lower segment Caesarean section under general anaesthesia (performed because of failure to progress in labour). Blood gases, electrolytes and full blood count post extubation are as follows:
Normal values |
||
Barometric pressure |
760mm Hg |
|
FiO2 |
0.5 |
|
pH |
7.31 |
7.35-7.45 |
pO2 |
150mm Hg |
|
pCO2 |
42 mm Hg |
35-45 |
HCO3- |
20.3mmol/L |
21-30 |
Standard base excess |
-5.0mmol/L |
|
Sodium |
137mmol/L |
135 -145 |
Potassium |
4.3mmol/L |
3.2 - 4.5 |
Chloride |
106mmol/L |
100 -110 |
Haemoglobin |
110g/L |
125 - 165 |
WCC |
19.8x 109/L |
4.0 - 11.0 |
Neutrophils |
17.3x 109/L |
1.8 - 7.5 |
Lymphocytes |
1.8x 109/L |
1.5 - 4.0 |
Describe and explain the acid-base status.
Calculate and interpret the A-a gradient.
What is the likely significance of the anaemia and leucocytosis?
The intention of this question is to test the candidates’ understanding of some important normal alterations in physiology due to pregnancy, and how this affects our interpretation of common ICU
data.
Acid-base status: Acute respiratory acidosis. Anion gap normal. At 38 weeks pregnancy the normal PaCO2 is <30 mm Hg with a compensatory reduction in bicarbonate. The blood gases therefore indicate acute CO2 retention, probably due to pain and narcotics. In the non-pregnant state these values would indicate an uncompensated normal anion gap metabolic acidosis. However these data must be interpreted in the light of the normal changes of pregnancy.
A-a gradient: There is a raised A-a gradient of 154 mm Hg, suggesting shunt and/or V/Q mismatch. Potential explanations are the loss of FRC after abdominal surgery, segmental collapse or consolidation, or aspiration.
Anaemia and leucocytosis: The mild anaemia is physiological in pregnancy, and the neutrophil leucocytosis is a normal feature during labour and early post-partum. This lady has been in labour prior to Caesarean section.
Sixteen out of twenty-six candidates passed this question.
This question is virtually identical to Question 9.2 from the second paper of 2011.
Whatever the reason, one identical question has been placed in the acid base disorders section, and another in the O&G section.
In this incarnation of the discussion section, I will focus on the normal changes which take place during pregnancy.
In summary:
There is a mild respiratory acidosis. The normal CO2 of late pregnancy is around 30mmHg, which is generally sustained with a bicarbonate of 20. In this scenario the bicarbonate has not changed, and the CO2 is elevated by 12mmHg. The use of the standard equation yields an expected pH of 7.304 for this change in CO2- very close to the measured pH (7.31), so there really is no metabolic acid-base disturbance at all.
The anion gap is normal if you calculate it without the potassium. It is 15.3 with potassium included, trivially elevated (by 3.3).
Chapter 64 (pp. 684) General obstetric emergencies by Winnie TP Wan and Tony Gin
Chapter 65 (pp. 692) Severe pre-existing disease in pregnancy by Jeremy P Campbell and Steve M Yentis
Carlin, Andrew, and Zarko Alfirevic. "Physiological changes of pregnancy and monitoring." Best Practice & Research Clinical Obstetrics & Gynaecology 22.5 (2008): 801-823.
Chesnutt, Asha N. "Physiology of normal pregnancy." Critical care clinics 20.4 (2004): 609-615.
Silversides, Candice K., and Jack M. Colman. "Physiological changes in pregnancy." Heart Disease in Pregnancy 2 (2007): 7-16.
List the likely causes of sudden respiratory distress in a woman in labour, who has no previous history of cardiac or respiratory disease. List 2 cardinal clinical features for each of these conditions.
a) Venous thromboembolism with PE: (Signs of DVT, Rt. Heart failure, ECG, CTPA)
b) Amniotic fluid embolus: Hemodynamic collapse with seizures, DIC
c) Pulm oedema secondary to pre-eclampsia: HT, proteinuria
d) Tocolytic pulmonary oedema: Tocolytic administration, rapid improvement
e) Aspiration pneumonitis – classic features
f) Peripartum cardiomyopathy: cardiomegaly, S3
g) Air embolism: Hypotension, cardiac mill wheel murmur
h) Pneumomediastinum: occurs during delivery
i) Other causes as in the non-pregnant patient
The college has actually only asked for two causes.
The list of causes generated by the college, however, is impressive.
1) Amniotic fluid embolism
Two features: DIC and right heart failure with cyanosis
2) Pulmonary embolism
Two features: increased A-a gradient and right heart strain on ECG
The belowmentioned article gives a list which looks a little like this:
The college would add:
To this list, I would add:
In general:
Cause | Cardinal features and brief discussion |
High epidural/spinal block |
|
Amniotic fluid embolism |
|
Pre-eclampsia leading to pulmonary oedema |
|
Tocolytic-associated pulmonary oedema |
|
Peripartum cardiomyopathy |
|
Air embolism |
|
Pneumomediastinum (also known as Hamman's syndrome) |
|
Accidental magnesium overdose |
|
Causes which are not unique to pregnancy, but which commonly co-exist with pregnancy | |
Sepsis |
|
Peripartum opiate use |
|
PE |
|
Fluid overload |
|
Aspiration |
|
Transfusion reaction |
|
Karetzky, Monroe, and Maria Ramirez. "Acute respiratory failure in pregnancy: an analysis of 19 cases." Medicine 77.1 (1998): 41-49. - this is a bit of a "royal sampler" of different causes of respiratory failure.
Chapter 64 (pp. 684) General obstetric emergencies by Winnie TP Wan and Tony Gin
Chapter 65 (pp. 692) Severe pre-existing disease in pregnancy by Jeremy P Campbell and Steve M Yentis
Lapinsky, Stephen E. "Acute respiratory failure in pregnancy." Obstetric Medicine: The Medicine of Pregnancy 8.3 (2015): 126-132.
Samanta, Sukhen, J. Wig, and A. K. Baronia. "How safe is the prone position in acute respiratory distress syndrome at late pregnancy?." (2014).
Rubal, Bernard J., et al. "The'mill-wheel'murmur and computed tomography of intracardiac air emboli." Journal of the American Association for Laboratory Animal Science 48.3 (2009): 300-302.
Lifschultz, Barry D., and Edmund R. Donoghue. "Air embolism during intercourse in pregnancy." Journal of Forensic Science 28.4 (1983): 1021-1022.
Balkan, M. Erkan, and Göknur Alver. "Spontaneous pneumomediastinum in 3rd trimester of pregnancy." Annals of thoracic and cardiovascular surgery 12.5 (2006): 362.
Jain, Vikyath. "Acute respiratory distress syndrome, Respiratory failure, Pregnancy." ACUTE RESPIRATORY DISTRESS SYNDROME IN PREGNANCY 7540 (2015).
Robinson, Julian N., et al. "Inhaled nitric oxide therapy in pregnancy complicated by pulmonary hypertension." American journal of obstetrics and gynecology 180.4 (1999): 1045-1046.
With respect to pregnancy,
a) indicate how the following variables change in the third trimester (either increase or decrease or no change)
Variable |
Direction of change |
Systolic blood pressure |
|
Diastolic blood pressure |
|
Heart rate |
|
Blood volume |
|
Haematocrit |
|
Tidal volume |
|
pH |
PCO2 |
|
PO2 |
|
Bicarbonate |
b) List 4 conditions specific to pregnancy which may result in right or left heart failure or both.
c) Outline the major differences in approach to cardiopulmonary resuscitation in pregnancy as compared to the non pregnant adult.
a) indicate how the following variables change in the third trimester (either increase or decrease or no change)
Variable |
Direction of change |
Systolic blood pressure |
Decrease |
Diastolic blood pressure |
Decrease |
Heart rate |
Increase |
Blood volume |
Increase |
Haematocrit |
Mild decrease |
Tidal volume |
Increase |
pH |
No change |
PCO2 |
Decrease |
PO2 |
Increase |
Bicarbonate |
Decrease |
b) List 4 conditions specific to pregnancy which may result in right or left heart failure or both.
Peripartum cardiomyopathy Pulmonary thromboembolism Amniotic fluid embolism Preclampsia
Tocolytic pulmonary oedema
c) Outline the major differences in approach to cardiopulmonary resuscitation in pregnancy as compared to the non pregnant adult.
1) CPR in left lateral position
2) Consideration of emergency Caesar
This question closely resembles Question 16 from the second paper of 2010.
In summary:
a)
Question a) specifically refers to Table 64.1 on page 685. A summary of the normal physiological changes in pregnancy can be found elsewhere.
b) is perfect as a list. Amniotic fluid embolism actually causes right heart failure at first, and then turns into LV failure. In fact, it would be even more perfect as a table:
This works best as a table. In fact, in Sliwa et al (2010) there is an even better table (Table 3. p.772)
Left-dominant | Right-dominant |
|
|
Potentially bi-ventricular:
|
c) is well discussed in the chapter on cardiac arrest in the pregnant patient. In short:
Keep in mind the following alternative causes of arrest:
Issues which complicate the pregnant arrest and peri-arrest scenario:
Manually displace the uterus to the left (off the aorta and vena cava)
To the college answer I might add that the emergency caesarian should be considered after 4 minutes of CPR, as per the ILCOR guidelines. The weirdly specific 27° pelvis tilt mentioned by the college can get you reaching for a protractor. It probably comes from the old AHA guidelines (these days the guideline-makers for the ECC and AHA no longer recommend the left lateral tilt (see the 2015 AHA update and the 2015 ECC guidelines).A left lateral tilt may compromise effective CPR, but is still recommended by the ARC Guideline 11.10 (2011) "Special Circumstances". Presumably, once the ARC get around to it, their guidelines will fall in line with international consensus. The 27° figure comes from Rees and Willis (1998), who got physicians to perform CPR on specially modified mannequins at different degrees of tilt. The authors found that the 27 degrees was the angle at which safe positioning and compression efficacy were at optimal compromise. Chest compression force was not too badly affected (80% of the force of compressions with the patient in a supine position), and the patient was unlikely to roll off the bed at this angle.
Einav, Sharon, Nechama Kaufman, and Hen Y. Sela. "Maternal cardiac arrest and perimortem caesarean delivery: evidence or expert-based?." Resuscitation 83.10 (2012): 1191-1200.
Morris Jr, John A., et al. "Infant survival after cesarean section for trauma." Annals of surgery 223.5 (1996): 481.
Beckett, V. A., P. Sharpe, and M. Knight. "CAPS—A UKOSS STUDY OF CARDIAC ARREST IN PREGNANCY AND THE USE OF PERI-MORTEM CAESAREAN SECTION. IMPLICATIONS FOR THE EMERGENCY DEPARTMENT." Emergency Medicine Journal 32.12 (2015): 995-995.
Elkady, A. A. "Peri-mortem Caesarean Section Delivery: A Literature Review and Comprehensive Overview." Enliven: Gynecol Obstet 2.3 (2015): 005.
Campbell, Tabitha A., and Tracy G. Sanson. "Cardiac arrest and pregnancy." Journal of emergencies, trauma, and shock 2.1 (2009): 34.
Katz, Vern L., Deborah J. Dotters, and William Droegemueller. "Perimortem cesarean delivery." Obstetrics & Gynecology 68.4 (1986): 571-576.
Manner, Richard L. "Court-Ordered Surgery for the Protection of a Viable Fetus:, 247 6a. 8b, 274 SE 2d 457 (1981)." (1982).
A 34 year old lady who is 34 weeks pregnant presents with acute onset epigastric pain. The plasma biochemistry and the haematology report are provided.
Test |
Normal Range |
Sodium 138 mmol/L |
135-145 |
Potassium 4.4 mmol/L |
3.2-4.5 |
Chloride 102 mmol/L |
100-110 |
Bicarbonate 27 mmol/L |
17-28 |
Anion Gap 9 mmol/L |
5-15 |
Creatinine 66 micromol/L |
50-100 |
Urea 4.3 mmol/L |
1.0-5.0 |
Tot Protein 76 H g/L |
55-75 |
Albumin 36 g/L |
28-38 |
Calcium 2.35 mmol/L |
2.00-2.50 |
Ca Alb Cor 2.53 H mmol/L |
2.00-2.50 |
Phosphate 1.03 mmol/L |
0.7-1.4 |
Magnesium 0.8 mmol/L |
0.7-1.0 |
Glucose 4.7 mmol/L |
3.6-7.7 |
CK Total 71 U/L |
<160 |
LD 748 H U/L |
100-200 |
AST 241 H U/L |
10-45 |
ALT 189 H U/L |
5-45 |
GGT 45 U/L |
10-70 |
ALP 185 H U/L |
65-180 |
Bilirubin Total 40 micromol/L |
<20 |
WCC 12.4 ^9/L |
4.0-15.0 |
1. What is the most likely diagnosis?
2. What 2 additional tests will support your diagnosis?
3. List 4 treatment options
1. What is the most likely diagnosis? HELLP
2. What 2 additional tests will support your diagnosis?
Haptoglobins : low
Blood film showing evidence of hemolysis
3. List 4 treatment options
1) This is HELLP syndrome. The platelets are low, the LDH is high, and there is raised bilirubin.
2) a blood film, reticulocyte count and serum haptoglobin would support this diagnosis
3) There is no specific management strategy for HELLP; delivery of the baby is the only "curative" procedure. Contrary to the college answer, neither plasma exchange nor corticosteroids have been show to improve maternal morbidity or mortality.
HELLP is discussed at lengths elsewhere.
You are called to the Emergency Department to review a nulliparous 28 year old woman. She is currently 35 weeks pregnant, and has presented with 72 hours of nausea and vomiting accompanied by epigastric and right upper quadrant pain. On examination she was jaundiced, confused and had a blood pressure of 120/70. Laboratory results from a venous blood taken on arrival are shown below:
Venous Blood |
Value |
Reference range |
Na+ |
138 |
135 -145 mmol/L |
K+ |
3.8 |
3.2-4.5 mmol/L |
Urea |
15 |
3.0-8.0 mmol/L |
Creatinine |
245 |
50-100 micromol/L |
Albumin |
30 |
33-40g/L |
Glucose |
2.5 |
3.0-7.8mmol/L |
Bilirubin (total) |
142 |
<20micromol/L |
ALP |
293 |
32-156 U/L |
AST |
99 |
<31U/L |
ALT |
88 |
<34U/L |
GGT |
67 |
<38U/L |
LDH |
180 |
110-250U/L |
Uric acid |
0.72 |
0.15-0.5 mmol/L |
APTT |
45 |
36-38 sec |
INR |
2.8 |
<1.2 |
Platelets |
123 |
150-450x109/L |
List 3 likely differential diagnoses for the above history and laboratory data
List 3 likely differential diagnoses for the above history and laboratory data
A number of differentials are possible however in the third trimester in a nulliparous woman the three main considerations are:
• Acute fatty liver of pregnancy ( AFLP):
• HELLP (Haemolysis, elevated liver enzymes and low platelets) Syndrome:
• Pre eclampsia with hepatic involvement.
Other considerations are: (these are not the cause of severe hepatic failure in pregnancy and so will attract fewer marks if mentioned without the first three)
• Intrahepatic Cholestasis of Pregnancy:
• Viral hepatitis: The commonest cause of jaundice in pregnancy. May occur at any time. The ALT and AST would be expected to be greatly elevated (>500-
1000U/L). DIC is rare.
Yes, the model answer lists at least 5 differentials, but the question asked for only "3 likely differential diagnoses".
Thus, one would be forced to mention the following:
Elaboration upon these syndromes is carried out in the discussion of Question 6 from the first paper of 2010.
In too mich detail, here are the causes of acute liver failure in pregnancy:
Cause | Diagnostic features | Notes and management options |
Causes of liver failure which are unrelated to pregnancy | ||
Drug-induced hepatitis |
|
|
Shock, haemorrhage |
|
|
Decompensation of pre-existing liver disease |
|
|
Causes of liver failure which are exacerbated by pregnancy | ||
Viral hepatitis |
|
|
Portal vein thrombosis |
|
|
Hepatic venous thrombosis |
|
|
Cholecystitis |
|
|
Pregnancy-related causes of liver failure | ||
Hyperemesis gravidarum |
|
|
Intrahepatic cholestasis of pregnancy (icterus gravidarum) |
|
|
Pre-eclampsia |
|
|
HELLP |
|
|
Acute fatty liver of pregnancy |
|
|
Acute hepatic rupture |
|
|
Other causes of febrile jaundiced coma with thrombocytopenia | ||
TTP/HUS |
|
|
Sepsis with DIC |
|
A 35 year old female is 39 weeks pregnant. Her pregnancy has been complicated by hypertension and proteinuria. Her blood pressure is 160/120 mm Hg. You are called to the labour ward when she suffers a generalised (“grand mal”) convulsion. Outline your overall plan of management.
Initial management
ABC
Left side
Terminate the seizure
a. Diazepam 5-10mg or Mg 4g IV up to 8 g
Monitors / investigations
Management of Hypertension
Hydrallazine
Labetalol
(Other agents are acceptable – late in pregnancy – increasing trend to use
“mainstream” agents)
Treatment of convulsions
MgSO4 bolus followed by maintenance MgSO4
(Shown to be more effective than phenytoin or diazepam in preventing recurrent seizures)
Addition of Benzodiazepine / Barbiturate if recurrent seizures despite MgSO4
Planning for delivery
Brief period of resuscitation once seizures controlled
Post partum management
Continue anti-convulsants until patient improves (diuresis, fall in BP)
This question closely resembles Question 23 from the first paper of of 2011.
Also, that's not how you spell hydralazine.
Anyway, the management should look like this:
Heres an article by Baha Sibai, who came up with the Tennessee classification for the HELLP syndrome:
Sibai, Baha M. "Diagnosis, prevention, and management of eclampsia."Obstetrics & Gynecology 105.2 (2005): 402-410.
Outline the challenges specifically associated with the management of a pregnant patient with status asthmaticus.
1) Pregnancy can worsen asthma – pulmonary congestion, reflux disease, low FRC
2) Because of reduced respiratory reserve, decompensation can be rapid
3) Need to be aware of the changes in blood gas reference values
4) Medications –
a) Steroids – potential malformations in the fetus if used in the first trimester – cleft lip
b) Beta 2 agonists- risk of tocolytic pulmonary oedema - delay in onset of labour
5) Sedation of the ventilated pregnant patient
Benzodiazepines – floppy infant syndrome
Opiates- fetal respiratory depression
If need for prolonged paralysis – risk of arthrogyphosis in the fetus
6) IPPV –
High risk intubation
Avoid nasal intubation
High pressures may reflect raised intraabdominal pressures
7) Maternal hypercapnia – reduces uteroplacental blood flow
Also shifts oxyHb dissociation curve in the fetus to the right, thus impairing fetal oxygenation – fetal monitoring essential
Long term maternal hypoxia associated with IUGR
8) NIV – may be difficult with increased risk of aspiration
9) Positioning of patient issues – Risk of aortocaval compression
The management of the pregnant asthmatic in the ICU is dealt with elsewhere.
To approach it systematically:
Main issues in pregnancy which complicate asthma:
Airway control:
Ventilation:
Circulatory support:
Neuromuscular blockade:
Specific management:
Avoid harmful strategies:
Bakhireva, Ludmila N., et al. "Asthma control during pregnancy and the risk of preterm delivery or impaired fetal growth." Annals of Allergy, Asthma & Immunology 101.2 (2008): 137-143.
Schatz, Michael, and Mitchell P. Dombrowski. "Asthma in pregnancy." New England Journal of Medicine 360.18 (2009): 1862-1869.
14.1 Outline briefly the difficulties associated with the diagnosis of sepsis during pregnancy and labour.
14.2 List the leading causes of sepsis in pregnant patients.
14.3 What are the common pathogens encountered in pregnancy related sepsis?
14.4 List 2 antibiotics contraindicated during pregnancy.
14.1 Outline briefly the difficulties associated with the diagnosis of sepsis during pregnancy and labour.
Applying SIRS criteria to pregnancy may be problematic as there is:
1) Leukocytosis
2) Body temperature is raised during pregnancy and labour
3) Tachycardia and tachypnoea are seen during normal labour
14.2 List the leading causes of sepsis in pregnant patients.
1) Pyelonephritis
2) Chorioamnionits
3) Septic abortion
4) Episiotomy infections
5) Necrotising fasciitis
6) Septic thrombophlebitis
7) Aspiration pneumonia
14.3 What are the common pathogens encountered in pregnancy related sepsis?
Gram negative more common than Gram positive agents
E.Coli one of the common pathogens
Can also be polymicrobial – E.coli, Klebsiella
14.4 List 2 antibiotics contraindicated during pregnancy.
Tetracyclines
Chloramphenicol
a) Outline briefly the difficulties associated with the diagnosis of sepsis during late pregnancy and labour.
Problems of the obsolete definition of sepsis and SIRS:
Other problems (stolen from the LITFL entry on this topic)
b) List the leading causes of sepsis in pregnant patients.
also...
|
|
c) What are the common pathogens encountered in pregnancy-related sepsis?
Oh's Manual quotes the following bugs:
To this, the Sanford Guide adds a few:
(these are specific to chorioamnionitis and septic abortion)
d) List two antibiotics contra-indicated during pregnancy.
The full list:
Contraindicated antibiotics | Why |
Aminoglycosides in high doses | Increased uptake by neonatal kidney leads to increased nephrotoxicity (but apparently gentamicin is still relativey safe) |
Streptomycin | 8th cranial nerve damage |
Sulfonamides | Kernicterus in the newborn due to displacement of bilirubin off albumin, particularly if used shortly before birth. The specific culprit is sulfamethoxazole. Trimpethoprim appears to be relatively safer. |
Tetracyclines | Tetracyclines have nightmarish dental and bony effects. In fact, these drugs are contraindicated from 16th week of gestation all the way until the 7th year of extrauterine life. |
Quinolones | Quinolones cause birth defects (though it seems fluoroquinolones are safe, and it was really mainly nalidixic acid that was the culprit). |
Rifampicin | Seems to be somewhat teratogenic, mainly in animal studies (spina bifida and impaired osteogenesis seem to be the major consequences)- but in humans one may overlook this if rifampicin is strongly indicated (eg. treatment of lifethreatening tuberculosis) |
Fusidic acid | Like sulfonamides, causes displacement of bilirubin by competing with it for albumin binding |
Chloramphenicol | This "Grey baby syndrome" is the consequence of disrupted mitochondrial function, when chloramphenicol metabolites interfere with the electron transport chain. Foetal failure to properly metabolise chloraphenicol by glucourinidation seems to be to blame. |
Azole antifungals | Teratigenic and embryotoxic. The specific dangerous ones are ketoconazole fluconazole and voriconazole, earning a D classification. |
Echinocandins | Hard to discuss humans in the absence of real data, but in animals using normal treatment doses caspofungin and anidulafungin cause skeletal abnormalities, reduction of litter size, ossification and rib malformations. |
Flucytosine | Embryotoxic and in fact abortificant in the first trimester, which is hardly surprising given that its main metabolite is 5-fluorouracil |
Albendazole | Teratogenic and embryotoxic. If the pregnant lady has some sort of hideous helminthic parasitosis which cannot wait until after delivery, ivermectin is probably a safer alternative |
Foscarnet | Seems to be teratogenic in animals, but if your CV infection is so severe and resistant that you've failed primary therapy, the chances are that your foetus is already significantly damaged by congenital CMV. |
The college answer for Question 3.1 from the first paper of 2014 also lists nitrofurantoin, isoniazid and macrolides as drugs which are relatively contraindicated. This in fact, is not true:
Oh's Intensive Care manual: Chapter 64 (pp. 684) General obstetric emergencies by Winnie TP Wan and Tony Gin
Fernandez-Perez, Evans R., et al. "Sepsis during pregnancy." Critical care medicine 33.10 (2005): S286-S293.
van Dillen, Jeroen, et al. "Maternal sepsis: epidemiology, etiology and outcome." Current opinion in infectious diseases 23.3 (2010): 249-254.
Demers, P., et al. "Effects of tetracyclines on skeletal growth and dentition. A report by the Nutrition Committee of the Canadian Paediatric Society."Canadian Medical Association Journal 99.17 (1968): 849.
Bar-Oz, Benjamin, et al. "The safety of quinolones—a meta-analysis of pregnancy outcomes." European Journal of Obstetrics & Gynecology and Reproductive Biology 143.2 (2009): 75-78.
Erić, Mirela, and Ana Sabo. "Teratogenicity of antibacterial agents." Collegium antropologicum 32.3 (2008): 919-925.
A 20 year old primi-gravida presents at 37 weeks gestation with jaundice, headache, blurred vision and hypertension (140/90mmHg). The antenatal period was otherwise unremarkable. She is febrile, drowsy, pale, icteric and has pedal oedema. The uterus is palpated as for a full term pregnancy with a normal CTG trace. Examination is otherwise normal.
The following are her early blood results:
Hb* |
80 G/L |
(115-160) |
Platelets* |
52 x 109/L |
(140-400) |
INR* |
1.8 |
(0.9-1.3) |
APTT* |
55 seconds |
(25-38) |
LDH* |
654 U/L |
(110-250) |
Fibrinogen* |
1.0 G/L |
(1.5-4.0) |
Total Bilirubin* |
51µmol/L |
(<20) |
Urea* |
30 mmol/L |
(3-8) |
Creatinine* |
298 µmol/L |
(70-120) |
Potassium* |
5.1 mmol/L |
(3.2-4.5) |
(a) List 4 likely differential diagnoses for this clinical presentation.
(b) What other investigations would you order for this patient and why?
(c) List the important management interventions for each of your differential diagnoses.
(a) List 4 likely differential diagnoses for this clinical presentation.
• Pre-eclampsia
• HELLP Syndrome
• Sepsis with DIC
• HUS-TTP
• Acute fatty liver of pregnancy
(b) What other investigations would you order for this patient and why?
• Transaminases (full liver function tests) Assessment of HELLP
• Peripheral blood film smear
Evidence of haemolysis or MAHA
• Reticulocyte count, haptoglobins, conjugated/unconjugated bilirubin
Haemolysis screen
• Blood, sputum, urine and vaginal swab for MC&S Septic screen
• Urinalysis – protein, WBCs, RBCs, casts
Evidence of infection or proteinuria (pre-eclampsia)
• Renal tract ultrasound
Rule out obstruction
(c) List the important management interventions for each of your differential diagnoses.
a. Pre-eclampsia
i. Deliver baby
ii. Control BP
iii. Hydralazine, beta blockers
iv. SNP/GTN if intravenous agent required.
v. Prevention of seizures
vi. Magnesium sulphate
b. HELLP Syndrome
i. Deliver baby
ii. Regular monitoring of platelet count and liver function
iii. Supportive measures whilst observing in HDU for dangerous complications – hepatic haemorrhage/rupture, progressive renal failure, pulmonary oedema.
c. Sepsis with DIC
i. Timely delivery of baby in consultation with obstetrician.
ii. Early broad spectrum antibiotics.
iii. Cardiovascular support – adequate volume resuscitation and establish a MAP > 65mmHg.
d. HUS-TTP
i. Deliver the baby.
ii. Fresh frozen plasma
iii. Therapeutic plasma exchange
iv. Corticosteroid therapy
v. Monoclonal antibody therapy – Rituximab
e. Acute fatty liver of pregnancy
i. Timely delivery of baby once mother stabilised
ii. Correction of DIC
iii. Supportive therapy
iv. Monitoring and treatment of complications post delivery eg pancreatitis
v. Consideration for liver transplantation in with irreversible severe liver
failure despite delivery and aggressive supportive care
One cannot add very much to this question.
One also cannot help but notice that it closely resembles Question 28 from the second paper of 2013.The question has been slightly altered, but otherwise it is exactly the same.
(a) List 4 likely differential diagnoses for this clinical presentation.
Pre-eclampsia is present - on the basis of the hypertension
(b) What other investigations would you order for this patient and why?
(c) List the important management interventions for each of your differential diagnoses.
For all of them, expeditious delivery of the baby.
For all of them, correction of coagulopathy
For all of them, supportive measures and observation in critical care environment
For pre-eclampsia, standard management as routine
For HELLP, no specific management
For sepsis, IV antibiotics
For TTP, plasma exchange
For acute fatty liver of pregnancy, nothing specific until they need a transplant.
Brief summaries with references:
The UpToDate links for the college's differentials are here:
Oh's Intensive Care manual: Chapter 63 (pp. 677) Preeclampsia and eclampsia by Wai Ka Ming and Tony Gin
RCOG Guidelines for the management of severe pre-eclampsia/eclampsia (2006)
Haram, Kjell, Einar Svendsen, and Ulrich Abildgaard. "The HELLP syndrome: clinical issues and management. A review." BMC pregnancy and childbirth 9.1 (2009): 8.
Geary, Michael. "The HELLP syndrome." BJOG: An International Journal of Obstetrics & Gynaecology 104.8 (1997): 887-891.
With respect to pregnancy.
a. Indicate how the following variables change in the third trimester (either increase or decrease or no change).
Variable |
Direction of Change |
Systolic Blood Pressure |
|
Diastolic Blood Pressure |
|
Heart Rate |
|
Blood Volume |
|
Haematocrit |
|
Tidal Volume |
|
pH |
|
PCO2 |
|
PO2 |
|
Bicarbonate |
b. List 4 conditions specific to pregnancy which may result in right or left heart failure or both.
c. Outline the major differences in approach to cardiopulmonary resuscitation in pregnancy as compared to the non-pregnant adult.
a. Indicate how the following variables change in the third trimester (either increase or decrease or no change).
Variable |
Direction of Change |
Systolic Blood Pressure |
Decrease |
Diastolic Blood Pressure |
Decrease |
Heart Rate |
Increase |
Blood Volume |
Increase |
Haematocrit |
Mild decrease |
Tidal Volume |
Increase |
pH |
No change |
PCO2 |
Decrease |
PO2 |
Increase |
Bicarbonate |
Decrease |
b. List 4 conditions specific to pregnancy which may result in right or left heart failure or both.
• Peripartum cardiomyopathy
• Amniotic fluid embolism
• Pre-eclampsia
• Tocolytic pulmonary oedema
• Pulmonary thromboembolism
c. Outline the major differences in approach to cardiopulmonary resuscitation in pregnancy as compared to the non-pregnant adult.
• CPR in left lateral position (27 degree tilt)
• Consideration for emergency caesarian section
• Hands slightly higher on sternum for chest compressions
• Additional personnel / equipment for emergency c-section and neonatal resuscitation
This entire question draws heavily from Oh's Intensive Care manual: Chapter 64 (pp. 684) General obstetric emergencies by Winnie TP Wan and Tony Gin,
Question a) specifically refers to Table 64.1 on page 685. A summary of the normal physiological changes in pregnancy can be found elsewhere.
In summary:
a)
Question a) specifically refers to Table 64.1 on page 685. A summary of the normal physiological changes in pregnancy can be found elsewhere.
b) is perfect as a list. Amniotic fluid embolism actually causes right heart failure at first, and then turns into LV failure. In fact, it would be even more perfect as a table:
This works best as a table. In fact, in Sliwa et al (2010) there is an even better table (Table 3. p.772)
Left-dominant | Right-dominant |
|
|
Potentially bi-ventricular:
|
c) is well discussed in the chapter on cardiac arrest in the pregnant patient. In short:
Keep in mind the following alternative causes of arrest:
Issues which complicate the pregnant arrest and peri-arrest scenario:
Manually displace the uterus to the left (off the aorta and vena cava)
b) is perfect as a list. Amniotic fluid embolism actually causes right heart failure at first, and then turns into LV failure
To (c) I might add that the emergency caesarian should be considered after 4 minutes of CPR, as per the ILCOR guidelines. The weirdly specific 27° pelvis tilt mentioned by the college can get you reaching for a protractor. It probably comes from the old AHA guidelines (these days the guideline-makers for the ECC and AHA no longer recommend the left lateral tilt (see the 2015 AHA update and the 2015 ECC guidelines).A left lateral tilt may compromise effective CPR, but is still recommended by the ARC Guideline 11.10 (2011) "Special Circumstances". Presumably, once the ARC get around to it, their guidelines will fall in line with international consensus. The 27° figure comes from Rees and Willis (1998), who got physicians to perform CPR on specially modified mannequins at different degrees of tilt. The authors found that the 27 degrees was the angle at which safe positioning and compression efficacy were at optimal compromise. Chest compression force was not too badly affected (80% of the force of compressions with the patient in a supine position), and the patient was unlikely to roll off the bed at this angle.
Oh's Intensive Care manual: Chapter 64 (pp. 684) General obstetric emergencies by Winnie TP Wan and Tony Gin
ARC Guideline 11.10 (2011) "Special Circumstances".
Rees, G. A. D., and B. A. Willis. "Resuscitation in late pregnancy."Anaesthesia 43.5 (1988): 347-349.
You are called to assess a 38 year old female with respiratory failure in the Emergency Department. This is her first pregnancy and she is 28 weeks pregnant after several attempts at IVF. She is positive for Swine-Origin Influenza Virus (H1N1).
Arterial blood gas on a FiO2 of 0.8 shows:
Evaluation of the foetal heart reveals significant bradycardia.
a) Outline the specific challenges in this case that distinguish it from a similar illness in a previously healthy 38 year old male.
b) Outline your specific approach to the management of this case.
a) Outline the specific challenges in this case that distinguish it from a similar illness in a previously healthy 38 year old male.
• Precious pregnancy in older, primiparous patient.
• Known high incidence of morbidity and mortality in mother and foetus with H1N1
Influenza infection with severe CAP.
• Requirement to work closely with specialist obstetric team and rationalising potentially conflicting priorities eg. timing of delivery of foetus.
• Anatomical and Physiological considerations during pregnancy- elevated diaphragm and decreased FRC, decreased chest wall compliance, increased risk of aspiration during intubation, pressure of gravid uterus on IVC (and aorta) decreasing venous return (and increasing afterload) in the supine position.
• Maintaining effective foeto-placental circulation while optimising maternal outcome.
• Safety of various drugs in pregnancy eg. anti-virals, sedatives.
• History of severe asthma complicating current episode of severe CAP likely to make ventilatory strategy more complex.
• Importance of keeping family members well informed of considerations and likelihood of poor foetal outcome as priority will be given to mother’s survival.
b) Outline your specific approach to the management of this case.
Immediate-
• Clinical scenario described requires rapid resuscitation.
• Airway- Secure early, rapid sequence induction. Anticipate difficult airway (ensure help and difficult airway equipment available.
• Breathing- Ventilate with protective lung strategy. Example of Settings – SIMV/PC, FiO2-1.0 PC to achieve Tidal Volumes of 6-8ml/kg, Low rate- 6-8/min I:E ratio 1:3-4 to allow adequate expiratory time, PEEP 10-15cm titrated to oxygenation. Close monitoring with regular blood gas evaluation. Tolerate hypercapnia (although not ideal for foetus) if poorly compliant lungs. Position at least 30 degrees head-up to optimise respiratory mechanics. Sedate heavily to minimise oxygen consumption. Neuromuscular blockade if required to facilitate ventilation.
• Circulation-. Fluid resuscitate (likely to be volume depleted) to clinical endpoints, vasoconstrictors to maintain perfusion pressure (eg MAP>60mmHg). Assessment of cardiac output if unstable haemodynamics with these measures (eg. echocardiogram, PiCCO, PA catheter, ScVO2)- High cardiac output expected due to
pregnancy and infection. Inotropes if cardiac output low. Position slightly left lateral to relieve IVC compression.
• Early specialist obstetric evaluation to determine foetal condition, position of placenta and risk versus benefit of delivery of foetus may need to be considered carefully taking into consideration maternal and foetal factors.
If we trim the psychosocial fat away from the lean physiology, there are several considerations in the management of this ARDS patient
Specific challenges:
Major pregnancy-related limiting factors which complicate the management of ARDS are as follows:
Thus, a management strategy mentioning all the important points would resemble the following list:
Airway:
Ventilation:
Circulation:
Sedation
Foetal wellbeing:
Social issues:
Langenegger, Eduard, et al. "Severe acute respiratory infection with influenza A (H1N1) during pregnancy." SAMJ: South African Medical Journal 99.10 (2009): 713-716.
Chapter 64 (pp. 684) General obstetric emergencies by Winnie TP Wan and Tony Gin
Chapter 65 (pp. 692) Severe pre-existing disease in pregnancy by Jeremy P Campbell and Steve M Yentis
Lapinsky, Stephen E. "Acute respiratory failure in pregnancy." Obstetric Medicine: The Medicine of Pregnancy 8.3 (2015): 126-132.
Samanta, Sukhen, J. Wig, and A. K. Baronia. "How safe is the prone position in acute respiratory distress syndrome at late pregnancy?." (2014).
Rubal, Bernard J., et al. "The'mill-wheel'murmur and computed tomography of intracardiac air emboli." Journal of the American Association for Laboratory Animal Science 48.3 (2009): 300-302.
Lifschultz, Barry D., and Edmund R. Donoghue. "Air embolism during intercourse in pregnancy." Journal of Forensic Science 28.4 (1983): 1021-1022.
Balkan, M. Erkan, and Göknur Alver. "Spontaneous pneumomediastinum in 3rd trimester of pregnancy." Annals of thoracic and cardiovascular surgery 12.5 (2006): 362.
Jain, Vikyath. "Acute respiratory distress syndrome, Respiratory failure, Pregnancy." ACUTE RESPIRATORY DISTRESS SYNDROME IN PREGNANCY 7540 (2015).
Robinson, Julian N., et al. "Inhaled nitric oxide therapy in pregnancy complicated by pulmonary hypertension." American journal of obstetrics and gynecology 180.4 (1999): 1045-1046.
A 35 year old female is 39 weeks pregnant. Her pregnancy has been complicated by hypertension and proteinuria. Her blood pressure is 160/120 mm Hg. You are called to the labour ward when she suffers a generalised (“grand mal”) convulsion.
Outline your overall plan of management.
Initial management
ABC – ensure patent airway, oxygen via reservoir mask or bag-valve-mask assembly and
support ventilation as needed
Left lateral tilt
Terminate the seizure
Diazepam 5-10mg or Mg 4g IV up to 8 g
Monitors / investigations
Management of Hypertension
Hydrallazine
Labetalol
(Other agents are acceptable – late in pregnancy – increasing trend to use “mainstream”
agents)
Treatment of convulsions
MgSO4 bolus followed by maintenance MgSO4
(Shown to be more effective than phenytoin or diazepam in preventing recurrent seizures) Addition of Benzodiazepine / Barbiturate if recurrent seizures despite MgSO4
Planning for delivery
Brief period of resuscitation once seizures controlled.
Post partum management
Continue anti-convulsants until patient improves (diuresis, fall in BP).
This patient was having what can be described as "severe preeclampsia". The seizure pushes her over into the eclampsia territory.
Consequently, the management should look like this:
Heres an article by Baha Sibai, who came up with the Tennessee classification for the HELLP syndrome:
Sibai, Baha M. "Diagnosis, prevention, and management of eclampsia."Obstetrics & Gynecology 105.2 (2005): 402-410.
A 40-year-old woman who is 34 weeks pregnant, presents to hospital following a generalised tonic/clonic seizure lasting 5 minutes.
Organised into a familiar patern, the differentials for seizures in pregnancy look like this:
As far as the CT goes... When would you expose a pregnant woman to radiation?
In any case, this authoritative body states that
" Teratogenesis is not a major concern after diagnostic CT studies of the pelvis in pregnancy, because the radiation dose is generally too low to cause such effects."
Reasons an epileptic might have more seziures during pregnancy:
Weirdly, progensterone has an antiepileptic effect, and its levels are wildly elevated in pregnancy
Consequences to the foetus:
Beach, Robert L., and Peter W. Kaplan. "Seizures in pregnancy: diagnosis and management." International review of neurobiology 83 (2008): 259-271.
Walker, S. P., M. Permezel, and S. F. Berkovic. "The management of epilepsy in pregnancy." BJOG: An International Journal of Obstetrics & Gynaecology116.6 (2009): 758-767.
Chen, Yi-Hua, et al. "Affect of seizures during gestation on pregnancy outcomes in women with epilepsy." Archives of neurology 66.8 (2009): 979-984.
Otani, Koichi. "Risk factors for the increased seizure frequency during pregnancy and puerperium." Psychiatry and Clinical Neurosciences 39.1 (1985): 33-42.
Teramo, K., et al. "Fetal heart rate during a maternal grand mal epileptic seizure." Journal of Perinatal Medicine-Official Journal of the WAPM 7.1 (1979): 3-6.
LaJoie, Josiane, and Solomon L. Moshé. "Effects of seizures and their treatment on fetal brain." Epilepsia 45.s8 (2004): 48-52.
Klein, Pave, and Andrew G. Herzog. "Hormonal effects on epilepsy in women."Epilepsia 39.s8 (1998): S9-S16.
A 28-year-old 35-week pregnant woman presents to the Emergency Department with acute onset epigastric pain. The biochemical profile and haematology report are as follows:
Parameter |
Result |
Normal Range |
Sodium |
138 mmol/L |
135 – 145 |
Potassium |
4.4 mmol/L |
3.2 –4.5 |
Chloride |
102 mmol/L |
100 – 110 |
Bicarbonate |
27 mmol/L |
22 – 27 |
Urea |
4.3 mmol/L |
3.0–8.0 |
Creatinine |
0.07 mmol/L |
0.07 – 0.12 |
Calcium |
2.35 mmol/L |
2.15 – 2.6 |
Corrected Calcium |
2.53 mmol/L |
2.15 – 2.8 |
Phosphate |
2.75 mmol/L* |
0.7 –1.4 |
Magnesium |
0.8 mmol/L |
0.7 –1.0 |
Glucose |
4.7 mmol/L |
3.6 –7.7 |
Albumin |
36 G/L |
33 – 47 |
CK |
71 U/L |
<160 |
Total Bilirubin |
40 micromol/L* |
4 – 20 |
GGT |
45 U/L |
0 – 50 |
ALP |
185 U/L* |
40 – 110 |
LDH |
748 U/L* |
110 – 250 |
AST |
241 U/L* |
<40 |
ALT |
189 U/L* |
<40 |
Haemoglobin |
88 G/L* |
110 – 160 |
White Cell Count |
12.4 x 109/L |
4.0 –15.0 |
Platelets |
64 x 109/L* |
150 – 400 |
The diagnosis and management of HELLP syndrome is well covered elsewhere.
The things to look for:
Thus, one would order the following tests:
Oh's Intensive Care manual: Chapter 63 (pp. 677) Preeclampsia and eclampsia by Wai Ka Ming and Tony Gin
Haram, Kjell, Einar Svendsen, and Ulrich Abildgaard. "The HELLP syndrome: clinical issues and management. A review." BMC pregnancy and childbirth 9.1 (2009): 8.
A 20-year-old primigravida presents at 37 weeks gestation with jaundice, headache, blurred vision and hypertension (140/90 mmHg). The antenatal period was otherwise unremarkable. She is febrile, drowsy, pale, icteric and has pedal oedema. The uterus is palpated as for a full term pregnancy with a normal CTG trace. Examination is otherwise normal.
The following are her early blood results:
Parameter |
Patient Value |
Normal Adult Range |
Hb |
80 G/L* |
115 – 160 |
Platelets |
52 x 109/L* |
140 – 400 |
International Normalised Ratio |
1.8* |
0.9 – 1.3 |
Activated Partial Thromboplastin Time |
55 seconds* |
25 – 38 |
Lactate Dehydrogenase |
654 U/L* |
110 – 250 |
Fibrinogen |
1.0 G/L* |
1.5 – 4.0 |
Total Bilirubin |
51 micromol/L* |
< 20 |
Urea |
30 mmol/L* |
3 – 8 |
Creatinine |
298 micromol/L* |
70 – 120 |
Potassium |
5.1 mmol/L* |
3.2 – 4.5 |
a) List four likely diagnoses for this clinical presentation.
b) For each of your differential diagnoses:
a)
b)
Pre-eclampsia
HELLP Syndrome
Sepsis with DIC
HUS-TTP
Acute fatty liver of pregnancy
This question closely resembles Question 6 from the first paper of 2010.
The college has yielded five differentials, each of which deserve a whole chapter dedicated to them.
There is little to add to the sufficently detailed yet concise college answer.
One must remember that in most of these conditions, the key step is to deliver the baby.
The one critical investigations for each differential would be...
A more complete list:
Cause | Diagnostic features | Notes and management options |
Causes of liver failure which are unrelated to pregnancy | ||
Drug-induced hepatitis |
|
|
Shock, haemorrhage |
|
|
Decompensation of pre-existing liver disease |
|
|
Causes of liver failure which are exacerbated by pregnancy | ||
Viral hepatitis |
|
|
Portal vein thrombosis |
|
|
Hepatic venous thrombosis |
|
|
Cholecystitis |
|
|
Pregnancy-related causes of liver failure | ||
Hyperemesis gravidarum |
|
|
Intrahepatic cholestasis of pregnancy (icterus gravidarum) |
|
|
Pre-eclampsia |
|
|
HELLP |
|
|
Acute fatty liver of pregnancy |
|
|
Acute hepatic rupture |
|
|
Other causes of febrile jaundiced coma with thrombocytopenia | ||
TTP/HUS |
|
|
Sepsis with DIC |
|
The UpToDate links for the college's differentials are here:
a) Outline briefly the difficulties associated with the diagnosis of sepsis during late pregnancy and labour.
b) List the leading causes of sepsis in pregnant patients.
c) What are the common pathogens encountered in pregnancy-related sepsis?
d) List two antibiotics contra-indicated during pregnancy.
a) Applying SIRS criteria to pregnancy may be problematic as there is:
1. Leukocytosis
2. Body temperature is raised during pregnancy and labour
3. Tachycardia and tachypnoea are seen during normal labour
b)
1. Pyelonephritis
2. Chorioamnionits
3. Septic abortion
4. Episiotomy infections
5. Necrotising fasciitis
6. Septic thrombophlebitis
7. Aspiration pneumonia
c)
1. Gram negative more common than Gram positive agents
2. E.Coli
3. Group B Streptococcus
4. Can also be polymicrobial – E.coli, Klebsiella
d)
1. Tetracyclines
2. Chloramphenicol
3. Aminoglycosides
4. Metronidazole
5. Sulphonamides
6. Trimethoprim
7. Fluoroquinolones
8. Some macrolides
9. Nitrofurantoin
10. Isoniazid
Note: Some antibiotics in the above list are relatively rather than absolutely contra-indicated. The list is not exclusive and candidates giving other valid choices were given credit.
a) Outline briefly the difficulties associated with the diagnosis of sepsis during late pregnancy and labour.
Problems of the obsolete definition of sepsis and SIRS:
Other problems (stolen from the LITFL entry on this topic)
b) List the leading causes of sepsis in pregnant patients.
also...
|
|
c) What are the common pathogens encountered in pregnancy-related sepsis?
Oh's Manual quotes the following bugs:
To this, the Sanford Guide adds a few:
(these are specific to chorioamnionitis and septic abortion)
d) List two antibiotics contra-indicated during pregnancy.
The full list:
Contraindicated antibiotics | Why |
Aminoglycosides in high doses | Increased uptake by neonatal kidney leads to increased nephrotoxicity (but apparently gentamicin is still relativey safe) |
Streptomycin | 8th cranial nerve damage |
Sulfonamides | Kernicterus in the newborn due to displacement of bilirubin off albumin, particularly if used shortly before birth. The specific culprit is sulfamethoxazole. Trimpethoprim appears to be relatively safer. |
Tetracyclines | Tetracyclines have nightmarish dental and bony effects. In fact, these drugs are contraindicated from 16th week of gestation all the way until the 7th year of extrauterine life. |
Quinolones | Quinolones cause birth defects (though it seems fluoroquinolones are safe, and it was really mainly nalidixic acid that was the culprit). |
Rifampicin | Seems to be somewhat teratogenic, mainly in animal studies (spina bifida and impaired osteogenesis seem to be the major consequences)- but in humans one may overlook this if rifampicin is strongly indicated (eg. treatment of lifethreatening tuberculosis) |
Fusidic acid | Like sulfonamides, causes displacement of bilirubin by competing with it for albumin binding |
Chloramphenicol | This "Grey baby syndrome" is the consequence of disrupted mitochondrial function, when chloramphenicol metabolites interfere with the electron transport chain. Foetal failure to properly metabolise chloraphenicol by glucourinidation seems to be to blame. |
Azole antifungals | Teratigenic and embryotoxic. The specific dangerous ones are ketoconazole fluconazole and voriconazole, earning a D classification. |
Echinocandins | Hard to discuss humans in the absence of real data, but in animals using normal treatment doses caspofungin and anidulafungin cause skeletal abnormalities, reduction of litter size, ossification and rib malformations. |
Flucytosine | Embryotoxic and in fact abortificant in the first trimester, which is hardly surprising given that its main metabolite is 5-fluorouracil |
Albendazole | Teratogenic and embryotoxic. If the pregnant lady has some sort of hideous helminthic parasitosis which cannot wait until after delivery, ivermectin is probably a safer alternative |
Foscarnet | Seems to be teratogenic in animals, but if your CV infection is so severe and resistant that you've failed primary therapy, the chances are that your foetus is already significantly damaged by congenital CMV. |
The college answer for Question 3.1 from the first paper of 2014 also lists nitrofurantoin, isoniazid and macrolides as drugs which are relatively contraindicated. This in fact, is not true:
Chapter 64 (pp. 684) General obstetric emergencies by Winnie TP Wan and Tony Gin
Chapter 65 (pp. 692) Severe pre-existing disease in pregnancy by Jeremy P Campbell and Steve M Yentis
Fernandez-Perez, Evans R., et al. "Sepsis during pregnancy." Critical care medicine 33.10 (2005): S286-S293.
Barton, John R., and Baha M. Sibai. "Severe sepsis and septic shock in pregnancy." Obstetrics & Gynecology 120.3 (2012): 689-706.
van Dillen, Jeroen, et al. "Maternal sepsis: epidemiology, etiology and outcome." Current opinion in infectious diseases 23.3 (2010): 249-254.
Khan, Muhammad R., and Sameer ur Rehman. "Sigmoid volvulus in pregnancy and puerperium: a surgical and obstetric catastrophe. Report of a case and review of the world literature." World Journal of Emergency Surgery 7.1 (2012): 1.
Demers, P., et al. "Effects of tetracyclines on skeletal growth and dentition. A report by the Nutrition Committee of the Canadian Paediatric Society."Canadian Medical Association Journal 99.17 (1968): 849.
Bar-Oz, Benjamin, et al. "The safety of quinolones—a meta-analysis of pregnancy outcomes." European Journal of Obstetrics & Gynecology and Reproductive Biology 143.2 (2009): 75-78.
Erić, Mirela, and Ana Sabo. "Teratogenicity of antibacterial agents." Collegium antropologicum 32.3 (2008): 919-925.
Chen, Morie M., et al. "Guidelines for computed tomography and magnetic resonance imaging use during pregnancy and lactation." Obstetrics & Gynecology 112.2, Part 1 (2008): 333-340.
Mylonas, Ioannis. "Antibiotic chemotherapy during pregnancy and lactation period: aspects for consideration." Archives of gynecology and obstetrics 283.1 (2011): 7-18.
Pilmis, Benoît, et al. "Antifungal drugs during pregnancy: an updated review." Journal of Antimicrobial Chemotherapy (2014): dku355.
David, S. Ben, et al. "The safety of nitrofurantoin during the first trimester of pregnancy: meta‐analysis." Fundamental & clinical pharmacology 9.5 (1995): 503-507.
Lin, Kueiyu Joshua, et al. "Safety of macrolides during pregnancy." American journal of obstetrics and gynecology 208.3 (2013): 221-e1.
Bar-Oz, Benjamin, et al. "Pregnancy outcome after gestational exposure to the new macrolides: a prospective multi-center observational study." European Journal of Obstetrics & Gynecology and Reproductive Biology 141.1 (2008): 31-34.
Ormerod, P. "Tuberculosis in pregnancy and the puerperium." Thorax 56.6 (2001): 494-499.
A 26-year-old female presents from home confused with a low-grade fever. Her blood pressure is 160/100 mmHg. She has no gross motor deficits on neurological examination.
Ten days prior to this presentation, she had induction of labour and delivery of a still-born foetus, at 32 weeks gestation, complicated by disseminated intravascular coagulation. She had been on labetalol for pregnancy-induced hypertension.
Her discharge medications included paracetamol, tramadol and a selective serotonin reuptake inhibitor. She has a six-year history of uncomplicated Hepatitis C infection.
a) List the differential diagnoses for her confusion and temperature.
b) Outline your approach to establishing the diagnosis.
a)
Pregnancy related: Eclampsia / preeclampsia / HELLP, Posterior reversible encephalopathy
syndrome (PRES), Hypertensive encephalopathy
Primary neurological: Infection (meningitis / encephalitis), cerebral venous thrombosis, seizure
disorder, other cerebro-vascular
Metabolic: Sodium (hypo/hyper), Glucose (hypo/hyper), Renal failure, Liver failure (HCV /
Paracetamol / Antidepressants),
Drugs: Accidental / intentional overdose, drug reactions (serotonin syndrome)
b)
History: Collateral, Pregnancy issues, Ongoing blood loss, bleeding / bruising, drug ingestions, mood
/ affect, headaches
Examination: BP, uterine size / discharge, oedema, meningism, neurological (tone, reflexes,
symmetry), chronic liver disease
Investigations:
FBC: Bleeding, platelets, WCC
UEC: urea / creatinine, Na, Ca, glucose
Coagulation: DIC, INR for CLD
LFT / Ammonia: hepatic encephalopathy, drug reactions ABG: hypoxia / hypercardia
Urinary drug screen / paracetamol level
Sepsis Screen, CT head +/- LP
This works better if it is presented in the form of a table
Causes | Investigations |
Vascular causes:
|
|
Infectious causes:
|
|
Drug-related causes:
|
|
Intrinsic neurological cause
|
|
Autoimmune causes
|
|
Traumatic or environmental causes
|
|
Endocrine and metabolic causes:
|
|
Differentials specific to pregnancy:
|
|
Oh's Intensive Care manual: Chapter 63 (pp. 677) Preeclampsia and eclampsia by Wai Ka Ming and Tony Gin
RCOG Guidelines for the management of severe pre-eclampsia/eclampsia (2006)
Duckitt, Kirsten, and Deborah Harrington. "Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies." Bmj 330.7491 (2005): 565.
Lorquet, Sophie, et al. "Aetiology and physiopathology of preeclampsia and related forms." Acta Clinica Belgica 65.4 (2010): 237-241.
Young, Brett C., Richard J. Levine, and S. Ananth Karumanchi. "Pathogenesis of preeclampsia." Annual Review of Pathological Mechanical Disease 5 (2010): 173-192.
Altman, D., et al. "Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial."Lancet 359.9321 (2002): 1877-1890.
Beach, Robert L., and Peter W. Kaplan. "Seizures in pregnancy: diagnosis and management." International review of neurobiology 83 (2008): 259-271.
Walker, S. P., M. Permezel, and S. F. Berkovic. "The management of epilepsy in pregnancy." BJOG: An International Journal of Obstetrics & Gynaecology116.6 (2009): 758-767.
Chen, Yi-Hua, et al. "Affect of seizures during gestation on pregnancy outcomes in women with epilepsy." Archives of neurology 66.8 (2009): 979-984.
Otani, Koichi. "Risk factors for the increased seizure frequency during pregnancy and puerperium." Psychiatry and Clinical Neurosciences 39.1 (1985): 33-42.
Teramo, K., et al. "Fetal heart rate during a maternal grand mal epileptic seizure." Journal of Perinatal Medicine-Official Journal of the WAPM 7.1 (1979): 3-6.
LaJoie, Josiane, and Solomon L. Moshé. "Effects of seizures and their treatment on fetal brain." Epilepsia 45.s8 (2004): 48-52.
Klein, Pave, and Andrew G. Herzog. "Hormonal effects on epilepsy in women."Epilepsia 39.s8 (1998): S9-S16.
Vajda, Frank JE, et al. "Seizure control in antiepileptic drug‐treated pregnancy." Epilepsia 49.1 (2008): 172-176.
A 30-year-old female who is 34 weeks pregnant (G1PO) has presented with nausea and vomiting for 3 days with right upper quadrant pain. On examination she is confused, jaundiced with a blood pressure of 120/70 mmHg.
The following are results from a venous blood sample taken on admission:
Parameter |
Patient Value |
Normal Adult Range |
Sodium |
138 mmol/L |
135 - 145 |
Potassium |
3.8 mmol/L |
3.5 - 5.0 |
Urea |
15.0 mmol/L* |
3.0 - 8.0 |
Creatinine |
245 µmol/L* |
45 - 90 |
Albumin |
30 q/L* |
33 - 40 |
Glucose |
2.5 mmol/L* |
3.0 - 7.8 |
Bilirubin (total) |
142 umol/L* |
< 20 |
Alkaline phosphatase |
293 U/L* |
30 - 110 |
Aspartate aminotransferase |
99 U/L* |
< 31 |
Alanine aminotransferase |
88 U/L* |
< 34 |
y-Glutamyl transferase |
67 U/L* |
< 40 |
Lactate dehydrogenase |
180 U/L |
110 - 250 |
Uric acid |
0.72 mmol/L* |
0.15 - 0.50 |
Activated partial thromboplastin time |
45 sec* |
36 - 38 |
International normalised ratio |
2.8* |
0.9 - 1.3 |
Platelets |
123 x 109/L* |
150 - 450 |
List three likely differential diagnoses for the above clinical picture. (30% marks)
Additional Examiners‟'Comments:
Many candidates did not complete part 2.
The abnormalities are:
Thus, this is pre-eclampsia, or something along the spectrum between pre-eclampsia and HELLP syndrome. A distant third possibility is TTP-HUS, but the LDH is within the normal range, which means that there is probably no haemolysis.
Thus, the differentials might include
Such things are usually best described in the form of a table. Good articles inform the discussion, most notably the article by Guntupalli et al from the 2005 special pregnancy issue of Critical Care Medicine.
Cause | Diagnostic features | Notes and management options |
Causes of liver failure which are unrelated to pregnancy | ||
Drug-induced hepatitis |
|
|
Shock, haemorrhage |
|
|
Decompensation of pre-existing liver disease |
|
|
Causes of liver failure which are exacerbated by pregnancy | ||
Viral hepatitis |
|
|
Portal vein thrombosis |
|
|
Hepatic venous thrombosis |
|
|
Cholecystitis |
|
|
Pregnancy-related causes of liver failure | ||
Hyperemesis gravidarum |
|
|
Intrahepatic cholestasis of pregnancy (icterus gravidarum) |
|
|
Pre-eclampsia |
|
|
HELLP |
|
|
Acute fatty liver of pregnancy |
|
|
Acute hepatic rupture |
|
|
Other causes of febrile jaundiced coma with thrombocytopenia | ||
TTP/HUS |
|
|
Sepsis with DIC |
|
Chapter 64 (pp. 684) General obstetric emergencies by Winnie TP Wan and Tony Gin
Chapter 65 (pp. 692) Severe pre-existing disease in pregnancy by Jeremy P Campbell and Steve M Yentis
Pandey, Chandra Kant, et al. "Acute liver failure in pregnancy: Challenges and management." Indian journal of anaesthesia 59.3 (2015): 144.
Sahai, Shweta, and Ravi Kiran. "Acute liver failure in pregnancy: Causative and prognostic factors." Saudi journal of gastroenterology: official journal of the Saudi Gastroenterology Association 21.1 (2015): 30.
Guntupalli, Saketh R., and Jay Steingrub. "Hepatic disease and pregnancy: an overview of diagnosis and management." Critical care medicine 33.10 (2005): S332-S339.
Aggarwal, Neelam, et al. "Pregnancy and cirrhosis of the liver." Australian and New Zealand journal of obstetrics and gynaecology 39.4 (1999): 503-506.
Horowitz, Rivka S., et al. "Placental transfer of N-acetylcysteine following human maternal acetaminophen toxicity." Journal of Toxicology: Clinical Toxicology 35.5 (1997): 447-451.
Outlaw, William M., Jamal A. Ibdah, and Kenneth L. Koch. "Hyperemesis Gravidarum and Maternal Liver Disease." (2000).
Munazza, Bibi, et al. "Liver function tests in preeclampsia." J Ayub Med Coll Abbottabad 23.4 (2011): 3-5.
Manas, Kenneth J., et al. "Hepatic hemorrhage without rupture in preeclampsia." New England Journal of Medicine 312.7 (1985): 424-426.
Kang, Yun Dan. "Portal Vein Thrombosis during Pregnancy." Korean Journal of Perinatology 26.3 (2015): 245-249.
Casey, Brian M., and Susan M. Cox. "Cholecystitis in pregnancy." Infectious diseases in obstetrics and gynecology 4.5 (1996): 303-309.
McMinn, Johnny R., and James N. George. "Evaluation of women with clinically suspected thrombotic thrombocytopenic purpura‐hemolytic uremic syndrome during pregnancy." Journal of clinical apheresis 16.4 (2001): 202-209.
With respect to the coagulation status of a third trimester pregnant patient compared to that in the nonpregnant state, indicate the change you would anticipate for each test listed below:
Platelet count
Factor V, Vll, 'X, X levels
Fibrinogen level
Protein S level
(20% marks)
a) Platelet count: Decrease
b) Factors V, VII, IX, X level: Increase
c) Fibrinogen level: Increase
d) Protein S level: Decrease
The overall trend in pregnancy is towards hypercoagulability. In the third trimester, coagulation activity is about double that of normal. The best source to read further is probably the 2003 article by Katarina Bremme.
In brief:
Bremme, Katarina A. "Haemostatic changes in pregnancy." Best practice & research Clinical haematology 16.2 (2003): 153-168.
This question relates to the critically ill obstetric patient.
a) List the diagnostic criteria for peri-partum cardiomyopathy. (30%marks)
With respect to amniotic fluid embolism (AFE):
i. List six important risk factors.(30% marks)
ii. Outline the important clinical features.(40% marks)
a)
• Onset of heart failure in the last month of pregnancy or within 5 months post-partum
• Absence of an identifiable cause of heart failure
• Absence of recognizable heart disease prior to the last month of pregnancy
• LV systolic dysfunction demonstrated by classical echocardiographic criteria. The latter
may be characterized as an LV ejection fraction < 45%, fractional shortening < 30%, or
both, with or without an LV end-diastolic dimension 2.7 cm/m2 body surface area. (This
level of detail not expected)
b)
i. List six important risk factors
• Precipitous or tumultuous labour.
• Advanced maternal age.
• Caesarean and instrumental delivery.
• Placenta previa and abruption.
• Grand multi-parity (≥5 live births or stillbirths),
• Cervical lacerations.
• Foetal distress.
• Eclampsia.
• Medical induction of labour.
• Polyhydramnios
ii. Outline the important clinical features of amniotic fluid embolism
• The onset of the symptoms and signs of amniotic fluid embolism syndrome
(AFES) most commonly occurs during labour and delivery, or immediately
postpartum
• Non-specific symptoms – chills, nausea, vomiting, agitation
• Hypotension due to cardiogenic shock
• Hypoxemia and respiratory failure
• Disseminated intravascular coagulation
• Coma or seizures
a)
In actual fact there are several competing definitions, of which the college offers one which is probably the least vague. Here is a table from the ESC statement (Sliwa et al, 2010)
Characteristic features of peripartum cardiomyopathy (also from Sliwa et al):
b)
To mix up the college answer with an article by Knight et al (2012)
Cardinal clinical features:
Other associated features are listed by Moore et al (2005):
Moore, Jason, and Marie R. Baldisseri. "Amniotic fluid embolism." Critical care medicine 33.10 (2005): S279-S285.
Meyer, JR "Embolia pulmonar amnio caseosa". Brasil Medico. 1926; 2:301.
Attwood, H. D. "The histological diagnosis of amniotic‐fluid embolism." The Journal of Pathology 76.1 (1958): 211-215.
Steiner, Paul E., and Clarence Chancelum Lushbaugh. "Maternal pulmonary embolism by amniotic fluid: as a cause of obstetric shock and unexpected deaths in obstetrics." Journal of the American Medical Association 117.15 (1941): 1245-1254.
Tuffnell, D. J. "United Kingdom amniotic fluid embolism register." BJOG: An International Journal of Obstetrics & Gynaecology 112.12 (2005): 1625-1629.
Conde-Agudelo, Agustín, and Roberto Romero. "Amniotic fluid embolism: an evidence-based review." American journal of obstetrics and gynecology 201.5 (2009): 445-e1.
Tamura, Naoaki, et al. "Amniotic fluid embolism: Pathophysiology from the perspective of pathology." Journal of Obstetrics and Gynaecology Research43.4 (2017): 627-632.
Sideris, Ioannis G., and Kypros H. Nicolaides. "Amniotic fluid pressure during pregnancy." Fetal diagnosis and therapy 5.2 (1990): 104-108.
Uyeno, Doko. "The physical properties and chemical composition of human amniotic fluid." Journal of Biological Chemistry 37.1 (1919): 77-103.
Lim, Y., et al. "Recombinant factor VIIa after amniotic fluid embolism and disseminated intravascular coagulopathy." International Journal of Gynecology & Obstetrics 87.2 (2004): 178-179.
Davies, Sharon. "Amniotic fluid embolism and isolated disseminated intravascular coagulation." Canadian Journal of Anesthesia 46.5 (1999): 456-459.
Kaneko, Yuhko, et al. "Continuous Hemodiafiltration for Disseminated Intrav ascular Coagulation and Shock due to Amniotic Fluid Embolism: Report of a Dramatic Response." Internal medicine 40.9 (2001): 945-947.
Awad, I. T., and G. D. Shorten. "Amniotic fluid embolism and isolated coagulopathy: atypical presentation of amniotic fluid embolism." European journal of anaesthesiology 18.6 (2001): 410-413.
Waters, Jonathan H., et al. "Amniotic fluid removal during cell salvage in the cesarean section patient." The Journal of the American Society of Anesthesiologists 92.6 (2000): 1531-1536.
Knight, Marian, et al. "Incidence and risk factors for amniotic-fluid embolism."Obstetrics & Gynecology 115.5 (2010): 910-917.
Knight, Marian, et al. "Amniotic fluid embolism incidence, risk factors and outcomes: a review and recommendations." BMC pregnancy and childbirth12.1 (2012): 7.
List the strategies available for the control of postpartum haemorrhage and give the advantages and disadvantages of each.
Tx |
Advantages |
Disadvantages |
Physical – vigorous bi-manual massage |
Immediate use, no specific equipment. |
Only works in uterine atony Worsens traumatic injury |
Pharmacological |
||
Oxytocin (first line) |
Simple, rapid action |
Hypotension and tachycardia Risk on the CVS unstable pt with no haemorrhage control |
Ergometrine (second line) |
Simple, rapid action |
Hypertension, N&V Vasospasm of the arteries in overdose-> gangrene, angina, ischaemia |
Prostaglandin (third line) Misoprostol PR Carboprost, IMI or intrauterine |
Simple |
B/Constriction, flushing Asthma is Contra Indic May inc pulmonary shunting and maternal hypoxia |
Surgical |
||
Manual removal of placenta/retained products |
Removes bleeding cause |
Needs GA in theatre |
Surgical repair Soft tissue trauma/artery ligation |
Definitive Tx |
Needs GA. |
Bakri Balloon +/- BT Cath |
Immediate control |
Infection risk Not definitive Tx Can mask ongoing bleeding. |
Hysterectomy |
Definitive Tx |
fertility |
Radiological |
||
Selective embolisation of pelvic vessels Balloon tamponade bilateral fermoral arteries as a temporizing measure REBOA |
May be definitive Can avoid hysterectomy |
Only available in tertiary centres Not suitable in catastrophic haemorrhage Temporising measure Risk of ischeamia to pelvic organs |
Maintain normal physiological milieu |
||
Avoid acidosis |
Not strictly a |
May not be effective alone |
Hypothermia Hypocalcaemia Correction of coagulopathy |
control option but will not allow normal haemostasis to occur if absent |
Correction of coagulopathy may require product transfusion with attendant possible complications |
Method | Advantages | Disadvantages |
Mechanical haemostasis methods | ||
Uterine massage |
|
|
Bimanual compression |
|
|
Manual aortic compression |
|
|
Pharmacological means of encouraging uterine contraction | ||
Oxytocin |
|
|
Ergometrine |
|
|
Carboprost |
|
|
Misoprostol |
|
|
Pharmacological measures to promote haemostasis | ||
Tranexamic acid |
|
|
Factor VIIa |
|
|
Surgical or radiological methods of haemostasis | ||
Gause pack tamponade |
|
|
Balloon tamponade |
|
|
Angio-embolisation |
|
|
Ligation of the uterine or common iliac artery |
|
|
Hysterectomy |
|
|
For extra credit, the trainees were expected to mention the WOMAN trial (Shakur et al, 2017). Bleeding PPH patients were randomised to receive 1g of tranexamic acid (and another 1g if needed). A whopping 20,060 patients were enrolled. The difference in death from haemorrhage was 1.5% vs 1.9%, in favour of tranexamic acid by 0.4% of absolute risk reduction - a difference which only achieved statistical significance because the numbers were massive and because the sample size was increased by 5000 patients mid-study. The number needed to treat are 267.
Oh's Manual, Chapter 64 ("General obstetric emergencies") by Winnie TP Wan and Tony Gin, p. 684
Mousa, Hatem A., et al. "Treatment for primary postpartum haemorrhage." The Cochrane Library (2014).
Oh's Manual, Chapter 64 ("General obstetric emergencies") by Winnie TP Wan and Tony Gin, p. 684
Mousa, Hatem A., et al. "Treatment for primary postpartum haemorrhage." The Cochrane Library (2014).
Tunçalp, Özge, G. Justus "Prostaglandins for preventing postpartum haemorrhage."Hofmeyr, and A. Metin Gülmezoglu. "Prostaglandins for preventing postpartum haemorrhage." Cochrane Database Syst Rev 8.8 (2012): CD000494.
Alfirevic, Zarko, et al. "Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000–2004." Obstetrics & Gynecology 110.6 (2007): 1270-1278.
Dahlke, Joshua D., et al. "Prevention and management of postpartum hemorrhage: a comparison of 4 national guidelines." American journal of obstetrics and gynecology 213.1 (2015): 76-e1.
Doumouchtsis, S. K., et al. "Menstrual and fertility outcomes following the surgical management of postpartum haemorrhage: a systematic review." BJOG: An International Journal of Obstetrics & Gynaecology 121.4 (2014): 382-388.
Smith, J., and H. A. Mousa. "Peripartum hysterectomy for primary postpartum haemorrhage: incidence and maternal morbidity." Journal of obstetrics and gynaecology 27.1 (2007): 44-47.
World Health Organization. WHO recommendations for the prevention and treatment of postpartum haemorrhage. World Health Organization, 2012.
Weeks, A. "The prevention and treatment of postpartum haemorrhage: what do we know, and where do we go to next?." BJOG: An International Journal of Obstetrics & Gynaecology122.2 (2015): 202-210.
Shakur et al "Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial." The Lancet 389.10084 (2017): 2105-2116.
A 25-year-old female with a 5-day history of anorexia, nausea and vomiting presents to hospital after a convulsion and is transferred immediately to your ICU. She is G3P2 and 30/40 gestation.The following blood results are obtained:
Parameter | Patient Value | Adult Normal Range | ||||||||||||||||||
Fi02 | 0.28 | |||||||||||||||||||
pH | 7.54* | 7.35 - 7.45 | ||||||||||||||||||
p02 | 87 mmHg (11.6 kPa) | |||||||||||||||||||
pC02 | 33.0 mmHg (4.4 kPa)* | 35.0 - 45.0 (4.6 - 6.0) | ||||||||||||||||||
Sp02 | 94% | |||||||||||||||||||
Bicarbonate | 28.0 mmol/L* | 22.0 - 26.0 | ||||||||||||||||||
Base Excess | 4.5 mmol/L* | -2.0 - +2.0 | ||||||||||||||||||
Sodium | 127 mmol/L* | 135 - 145 | ||||||||||||||||||
Potassium | 2.3 mmol/L* | 3.5 - 5.0 | ||||||||||||||||||
Chloride | 84 mmol/L* | 95 - 105 | ||||||||||||||||||
Glucose | 4.8 mmol/L | 3.5 - 6.0 | ||||||||||||||||||
Creatinine | 354 µmol/L* | 45 - 90 | ||||||||||||||||||
Urea | 29.0 mmol/L* | 3.0 - 8.0 | ||||||||||||||||||
Haemoglobin | 177 g/L* | 120 - 160 | ||||||||||||||||||
White Cell Count | 25.4 x 109/L* | j | 4.0 - 11.0 | |||||||||||||||||
Platelet count | 29 x 109/L* | I | 150 - 350 | |||||||||||||||||
Prothrombin time | 15.0 sec | 12.0 - 16.5 | ||||||||||||||||||
INR | 1.1 | 0.9 - 1.3 | ||||||||||||||||||
APTT | 28.0 sec | 27.0 - 38.5 | ||||||||||||||||||
Fibrinogen | 5.7 g/L* | , | 2.0 - 4.0 | |||||||||||||||||
D-Dimer | 16.8 mg/L* | / | < 0.5 |
Describe the important metabolic abnormalities and give one explanation for each.
(40% marks)
Describe the important abnormalities and give one explanation for each?
Systematically:
Outline the causes and management of severe postpartum haemorrhage (PPH).
Causes can be broken down into 4 main groups: the “4 T’s”
Tone: uterine atony (most common)
Trauma: Bleeding at surgical sites including episiotomy, genital tract laceration [vagina/cervix etc], uterine rupture
Tissue: Retained tissue (placenta) and/or membranes
Thrombin: Previously present or acquired maternal coagulation defect. Examples of acquired defects
include those seen in severe pre-eclampsia, severe sepsis, amniotic fluid embolism, placental abruption or in the setting of massive transfusion.
Management can be broken down into initial resuscitation and specific treatment, with specific treatment having surgical and non-surgical modalities. Resuscitation and treatment should occur simultaneously.
Resuscitation
ABCDE approach. Assemble team (ICU/Anaesthesia/Obstetrics etc)
Appropriate monitoring: ECG / NIBP / Arterial line / CVC if time or indication
Large bore IV access x2
Initial resuscitation with crystalloids / 4% albumin
Activation of PPH protocol
Activation of massive transfusion protocol / Use O neg blood (but likely to know blood group already and use group specific blood) early if no X matched blood available
No specific Hb triggers for when to use blood, suggested after no more than 30mls/kg resusc fluids or evidence of ongoing bleeding
Other products as required: NBA Obstetric guidelines suggest FFP 15mls/kg, platelets 1 pooled bag, cryoprecipitate 3-4g (8-10 bags): use local protocols if possible and involve specialist Haematologist. Keep fibrinogen >2.0 or replace if dropping (normal in pregnancy 4-6g/L: use cryoprecipitate or fibrinogen concentrate) Emphasis on early fibrinogen
Viscoelastic tests
Avoid hypothermia, hypocalcaemia and acidosis
Non-Surgical Treatment
Bimanual uterine compression
Pharmacological Therapy (uterotonics): oxytocin, misoprostol, prostaglandin F2 alpha
Tranexamic Acid (TXA): [the WOMAN trial showed a substantial mortality benefit if given within 3 hours]
Balloon tamponade (Bakri balloon)
Vaginal/Uterine packing
Interventional Radiology: selective arterial embolization/balloon tamponade Consider Factor VIIa as rescue therapy
Surgical treatment
EUA: repair of lacerations / evacuation of retained placental fragments etc
Laparotomy: Uterine or iliac artery ligation, B-lynch brace suture
Pelvic packing
Aortic compression / X clamp
Hysterectomy
Causes of PPH
It is not possible to add much to the (already comprehensive) list of causes offered by the model answer.
Management of PPH
This structure and a lot of the components are borrowed from the RANZCOG statement C-Obs 43.
Resuscitation
Specific management
Oh's Manual, Chapter 64 ("General obstetric emergencies") by Winnie TP Wan and Tony Gin, p. 684
Mousa, Hatem A., et al. "Treatment for primary postpartum haemorrhage." The Cochrane Library (2014).
Tunçalp, Özge, G. Justus "Prostaglandins for preventing postpartum haemorrhage."Hofmeyr, and A. Metin Gülmezoglu. "Prostaglandins for preventing postpartum haemorrhage." Cochrane Database Syst Rev 8.8 (2012): CD000494.
Alfirevic, Zarko, et al. "Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000–2004." Obstetrics & Gynecology 110.6 (2007): 1270-1278.
Dahlke, Joshua D., et al. "Prevention and management of postpartum hemorrhage: a comparison of 4 national guidelines." American journal of obstetrics and gynecology 213.1 (2015): 76-e1.
Doumouchtsis, S. K., et al. "Menstrual and fertility outcomes following the surgical management of postpartum haemorrhage: a systematic review." BJOG: An International Journal of Obstetrics & Gynaecology 121.4 (2014): 382-388.
Smith, J., and H. A. Mousa. "Peripartum hysterectomy for primary postpartum haemorrhage: incidence and maternal morbidity." Journal of obstetrics and gynaecology 27.1 (2007): 44-47.
World Health Organization. WHO recommendations for the prevention and treatment of postpartum haemorrhage. World Health Organization, 2012.
Weeks, A. "The prevention and treatment of postpartum haemorrhage: what do we know, and where do we go to next?." BJOG: An International Journal of Obstetrics & Gynaecology122.2 (2015): 202-210.
Edhi, Muhammad Muzzammil, et al. "Post partum hemorrhage: causes and management." BMC research notes6.1 (2013): 236.
Sheiner, Eyal, et al. "Obstetric risk factors and outcome of pregnancies complicated with early postpartum hemorrhage: a population-based study." The Journal of Maternal-Fetal & Neonatal Medicine 18.3 (2005): 149-154.
Mousa, Hatem A., and Steven Walkinshaw. "Major postpartum haemorrhage." Current opinion in Obstetrics and Gynecology13.6 (2001): 595-603.
Mousa, Hatem A., et al. "Treatment for primary postpartum haemorrhage." Cochrane Database Syst Rev 2.2 (2014): CD003249.
With regard to severe post-partum haemorrhage (PPH):
a) List the causes. (20% marks)
b) Outline the management. (80% marks)
Not available.
a) Causes of PPH
This structure and a lot of the components are borrowed from the RANZCOG statement C-Obs 43.
Resuscitation
Specific management
Oh's Manual, Chapter 64 ("General obstetric emergencies") by Winnie TP Wan and Tony Gin, p. 684
Mousa, Hatem A., et al. "Treatment for primary postpartum haemorrhage." The Cochrane Library (2014).
Tunçalp, Özge, G. Justus "Prostaglandins for preventing postpartum haemorrhage."Hofmeyr, and A. Metin Gülmezoglu. "Prostaglandins for preventing postpartum haemorrhage." Cochrane Database Syst Rev 8.8 (2012): CD000494.
Alfirevic, Zarko, et al. "Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000–2004." Obstetrics & Gynecology 110.6 (2007): 1270-1278.
Dahlke, Joshua D., et al. "Prevention and management of postpartum hemorrhage: a comparison of 4 national guidelines." American journal of obstetrics and gynecology 213.1 (2015): 76-e1.
Doumouchtsis, S. K., et al. "Menstrual and fertility outcomes following the surgical management of postpartum haemorrhage: a systematic review." BJOG: An International Journal of Obstetrics & Gynaecology 121.4 (2014): 382-388.
Smith, J., and H. A. Mousa. "Peripartum hysterectomy for primary postpartum haemorrhage: incidence and maternal morbidity." Journal of obstetrics and gynaecology 27.1 (2007): 44-47.
World Health Organization. WHO recommendations for the prevention and treatment of postpartum haemorrhage. World Health Organization, 2012.
Weeks, A. "The prevention and treatment of postpartum haemorrhage: what do we know, and where do we go to next?." BJOG: An International Journal of Obstetrics & Gynaecology122.2 (2015): 202-210.
Edhi, Muhammad Muzzammil, et al. "Post partum hemorrhage: causes and management." BMC research notes6.1 (2013): 236.
Sheiner, Eyal, et al. "Obstetric risk factors and outcome of pregnancies complicated with early postpartum hemorrhage: a population-based study." The Journal of Maternal-Fetal & Neonatal Medicine 18.3 (2005): 149-154.
Mousa, Hatem A., and Steven Walkinshaw. "Major postpartum haemorrhage." Current opinion in Obstetrics and Gynecology13.6 (2001): 595-603.
Mousa, Hatem A., et al. "Treatment for primary postpartum haemorrhage." Cochrane Database Syst Rev 2.2 (2014): CD003249.
Outline the causes and management of severe postpartum haemorrhage (PPH).
Not available.
This question is identical to Question 17 from the second paper of 2018, and is almost identical to the very similarly structured Question 3 from the second paper of 2020. Why they went back to the 2018 format is a mystery.
Causes of PPH
It is not possible to add much to the (already comprehensive) list of causes offered by the model answer.
Management of PPH
This structure and a lot of the components are borrowed from the RANZCOG statement C-Obs 43.
Resuscitation
Specific management
Oh's Manual, Chapter 64 ("General obstetric emergencies") by Winnie TP Wan and Tony Gin, p. 684
Mousa, Hatem A., et al. "Treatment for primary postpartum haemorrhage." The Cochrane Library (2014).
Tunçalp, Özge, G. Justus "Prostaglandins for preventing postpartum haemorrhage."Hofmeyr, and A. Metin Gülmezoglu. "Prostaglandins for preventing postpartum haemorrhage." Cochrane Database Syst Rev 8.8 (2012): CD000494.
Alfirevic, Zarko, et al. "Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000–2004." Obstetrics & Gynecology 110.6 (2007): 1270-1278.
Dahlke, Joshua D., et al. "Prevention and management of postpartum hemorrhage: a comparison of 4 national guidelines." American journal of obstetrics and gynecology 213.1 (2015): 76-e1.
Doumouchtsis, S. K., et al. "Menstrual and fertility outcomes following the surgical management of postpartum haemorrhage: a systematic review." BJOG: An International Journal of Obstetrics & Gynaecology 121.4 (2014): 382-388.
Smith, J., and H. A. Mousa. "Peripartum hysterectomy for primary postpartum haemorrhage: incidence and maternal morbidity." Journal of obstetrics and gynaecology 27.1 (2007): 44-47.
World Health Organization. WHO recommendations for the prevention and treatment of postpartum haemorrhage. World Health Organization, 2012.
Weeks, A. "The prevention and treatment of postpartum haemorrhage: what do we know, and where do we go to next?." BJOG: An International Journal of Obstetrics & Gynaecology122.2 (2015): 202-210.
Edhi, Muhammad Muzzammil, et al. "Post partum hemorrhage: causes and management." BMC research notes6.1 (2013): 236.
Sheiner, Eyal, et al. "Obstetric risk factors and outcome of pregnancies complicated with early postpartum hemorrhage: a population-based study." The Journal of Maternal-Fetal & Neonatal Medicine 18.3 (2005): 149-154.
Mousa, Hatem A., and Steven Walkinshaw. "Major postpartum haemorrhage." Current opinion in Obstetrics and Gynecology13.6 (2001): 595-603.
Mousa, Hatem A., et al. "Treatment for primary postpartum haemorrhage." Cochrane Database Syst Rev 2.2 (2014): CD003249.
A 25-year-old female with a 5-day history of anorexia, nausea and vomiting presents to hospital after a convulsion and is transferred immediately to your ICU. She is G3P2 and 30/40 gestation. The following blood results are obtained:
Parameter |
Patient Value |
Adult Normal Range |
FiO2 |
0.28 |
|
pH |
7.54* |
7.35 – 7.45 |
PO2 |
87 mmHg (11.6 kPa) |
|
PCO2 |
33.0 mmHg (4.4 kPa)* |
35.0 – 45.0 (4.6 – 6.0) |
SpO2 |
94% |
|
Bicarbonate |
28.0 mmol/L* |
22.0 – 26.0 |
Base Excess |
4.5 mmol/L* |
-2.0 – +2.0 |
Sodium |
127 mmol/L* |
135 – 145 |
Potassium |
2.3 mmol/L* |
3.5 – 5.0 |
Chloride |
84 mmol/L* |
95 – 105 |
Glucose |
4.8 mmol/L |
3.5 – 6.0 |
Creatinine |
354 µmol/L* |
45 – 90 |
Urea |
29.0 mmol/L* |
3.0 – 8.0 |
Haemoglobin |
177 g/L* |
120 – 160 |
White Cell Count |
25.4 x 109/L* |
4.0 – 11.0 |
Platelet count |
29 x 109/L* |
150 – 350 |
Prothrombin time |
15.0 sec |
12.0 – 16.5 |
International normalised ratio (INR) |
1.1 |
0.9 – 1.3 |
Activated partial thromboplastin time (APTT) |
28.0 sec |
27.0 – 38.5 |
Fibrinogen |
5.7 g/L* |
2.0 – 4.0 |
D-Dimer |
16.8 mg/L* |
< 0.5 |
a) Describe the important metabolic abnormalities and give one explanation for each.
(40% marks)
Not available.
This question is identical to Question 20.1 from the second paper of 2017, except this time the examiners added the word "important" to "abnormalities", presumably because the last bunch of answers were filled with pointless trivial abnormalities. The reader is left to decide, which of the following list of problems fits that description, and invited to pick whichever ones seem important enough to write in the span of four minutes.
Systematically:
Regarding peri-partum cardiomyopathy (PPCM):
a) Define peri-partum cardiomyopathy. (20% marks)
b) List five differential diagnoses. (20% marks)
c) Outline the management. (60% marks)
Not available.
a) Peripartum cardiomyopathy has some specific defining criteria:
This is from the ESC statement from 2010, and is probably enough for a sub-question worth only 20% of the marks. If one wanted to write a little extra, a previous college answer holds clues to what the college examiners think is a good definition:
This definition was generated by a panel of fourteen experts during a conference workshop (Pearson et al, 2000).
b) Five plausible differentials would include:
c) Management is same as you would manage acute heart failure from any cause:
Sliwa, Karen, et al. "Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy." European journal of heart failure 12.8 (2010): 767-778.
Pearson, Gail D., et al. "Peripartum cardiomyopathy: national heart, lung, and blood institute and office of rare diseases (national institutes of health) workshop recommendations and review." Jama 283.9 (2000): 1183-1188.
Sliwa, Karen, James Fett, and Uri Elkayam. "Peripartum cardiomyopathy." The Lancet 368.9536 (2006): 687-693.